Longitudinal Immune Responses and Gene Expression Profiles in Type 1 Leprosy ReactionsAnnemieke Geluk, Tom H. M. Ottenhoff, Krista E. van Meijgaarden et al.|Journal of Clinical Immunology|2013Cited by 69
A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and AfricaAngela Huttner, Claire‐Anne Siegrist, Peter G. Kremsner et al.|Science Translational Medicine|2017Cited by 64
Repurposing diphenylbutylpiperidine-class antipsychotic drugs for host-directed therapy of Mycobacterium tuberculosis and Salmonella enterica infectionsMatthias T. Heemskerk, Mariëlle C. Haks|Scientific Reports|2021Cited by 26
Human Transcriptomic Response to the VSV-Vectored Ebola VaccineFrancesco Santoro, Gianni Pozzi, Alessia Donato et al.|Vaccines|2021Cited by 22
Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker studyEleonora Vianello, Sylvia Rothenberger, Patrícia Gonzalez‐Dias et al.|The Lancet Microbe|2021Cited by 13